Home > Technology > Aortic valve sector growth provides attractive opportunities safe treatment

Aortic valve sector growth provides attractive opportunities safe treatment

Added: (Mon Mar 16 2020)

Pressbox (Press Release) - It is being expected that during the forecast period (2018–2023), the market will progress with a CAGR of 10.3%. At this rate, the revenue generated from the sale of such devices would grow from $5.6 billion in 2017 to almost $9.9 billion 0in 2023.

Aortic valve is a natural valve in the heart, which regulates the flow of blood from the left ventricle to the aorta. In a valvular heart disease, such as aortic valve regurgitation or aortic valve stenosis, the functioning of the valve is compromised, creating the need for a replacement. As per the 2016 Interventional Cardiology Journal, Valvular Heart Diseases - Epidemiology and New Treatment Modalities, and the 2006 Valvular Heart Disease in Elderly Adults report published by Nkomo et al, the risk of VHD increases with age.

Access Detailed Report Summary:
https://www.psmarketresearch.com/market-analysis/aortic-valve-market

The reports concluded that the prevalence of VHD was just 0.7% in people between 18 and 44 years of age, and almost 13.0% in those over 75 years old. The ongoing aortic valve market trend shows that the elderly are the largest consumers of such valves. According to the Health at A Glance 2017 report published by the Organisation for Economic Co-operation and Development, the percentage of people over 65 years old in member countries would rise from 17.0% in 2015 to 28.0% in 2050.

Request to Get the Sample Pages at:
https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample

Now, among the two types of valves transplanted in the human body — mechanical and tissue/biological — the latter dominated the market during the historical period (2013–2017) in terms of sales volume as well as value. In terms of value, tissue/biological valves held almost 65.0% share in the aortic valve market. Such valves, which are made from tissues of other animals, are quite flexible and can last up to 20 years. Further, people transplanted with biological/tissue valves do not require additional medication.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aortic-valve-market

Of the two types of procedures for aortic valve replacement, viz. open surgery and minimally-invasive surgery (MIS), the valves transplanted via MIS dominated the market in 2017 in terms of value. Further, even in MIS, there are two main approaches: transfemoral and transapical. Of these, the transfemoral approach consumed valves in the larger amount, contributing $2,397.8 million in revenue to the aortic valve market in 2017. It is further being predicted that the sale of aortic valves for transfemoral MIS will generate a revenue of $4,897.5 million by 2023.

Submitted by:Pramod Kumar
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.